The Goal Is Remission. Not Just Feeling A Little Better.
Medication management at Tri-MED is grounded in a single overarching principle: neuroplasticity. We use psychiatric medications not just to reduce symptoms, but to create the biological conditions in which your brain can genuinely heal and rewire.
Medication with a neuroplasticity lens
At Tri-MED, psychiatric medication isn’t the endpoint of care — it’s one instrument in a broader strategy. Our overarching framework is neuroplasticity: the brain’s capacity to change, repair, and rewire. Every medication decision we make is evaluated through that lens.
We begin with pharmacogenomic testing where indicated — because your CYP450 enzymes, your MTHFR status, and your drug-gene interactions are not guesses. They are data. Patients who have cycled through multiple medications without success are often carrying genetic variants that make standard dosing ineffective or poorly tolerated.
We also recognize that medications alone rarely produce remission in complex cases. When progress stalls, we don’t simply add another prescription. We ask why — and we escalate deliberately, with interventions chosen for their mechanism, not just their availability.
Medication that works with your brain
Pharmacogenomics
Your CYP450 enzymes, MTHFR variants, and drug-gene interactions determine how effectively your body processes psychiatric medications. We test where indicated — turning years of trial and error into a data-guided first step.
Neuroplasticity as the Goal
Medications that promote BDNF, support synaptic repair, and reduce neuroinflammation do more than manage symptoms — they create windows for genuine brain healing. We select and sequence agents with that biological objective in mind.
Biomarker-Informed Prescribing
Thyroid function, inflammatory markers, sex hormones, cortisol, vitamin D, B12 — these directly shape how psychiatric medications perform in your body. We read that context before prescribing, not after a medication fails to work.
How we think about medication
We aim for remission — not just response.
Response means your symptoms improved somewhat. Remission means they are in full or near-full resolution — and you feel like yourself again. These are different targets. We keep adjusting, escalating, and broadening the approach until remission is reached or we understand exactly why it isn’t.Stalled progress is a signal, not a dead end.
When medication alone isn’t producing adequate progress, we don’t add another prescription and hope for different results. We step back, ask why, and escalate deliberately — to interventions that work through fundamentally different mechanisms or address the biology that’s been blocking your response all along.The medication carousel has an exit — and we’ll find it.
Years of cycling through medications without lasting relief often signals a biological problem that medication alone cannot solve. In these cases, we may recommend our integrative functional medicine program — addressing neuroinflammation, metabolic dysfunction, genetics, and gut-brain factors that keep blocking your response.The next step is always purposeful
Naturopathic & Integrative Agents
Evidence-informed naturopathic interventions — targeted nutraceuticals, adaptogenic compounds, and specific micronutrient protocols — may be incorporated when the data supports it. These are not alternatives to good medicine. They are part of it, when applied with clinical precision.
Integrative Functional Medicine
Some patients cycling through medication trials are not failing medications — they are failing to have their underlying biology addressed. Neuroinflammation, insulin resistance, hormonal dysfunction, and genetic variants can all block medication response. Our integrative functional medicine program investigates and corrects these root causes — often breaking the cycle where pharmacotherapy alone cannot.
